Table 4 Comparison of HI, Average Dose to Organs at Risk, and Intergroup Comparisons for X = 15 and SP Groups.

From: Dosimetric evaluation of field parameters in VMAT for cervical cancer with inguinal lymphatic drainage extension

 

HI

Dmean_INT(Gy)

Dmean_BLA(Gy)

Dmean_REC(Gy)

X = 15

0.175 ± 0.113

25.93 ± 1.65

42.95 ± 2.16

42.48 ± 2.08

SP

0.166 ± 0.112

25.99 ± 1.65

42.59 ± 2.18

42.19 ± 2.16

P

0*

0.062

0*

0*

  1. A P value < 0.05 indicates a statistically significant difference, which is marked with an asterisk (*) in the table.